A Phase III, randomised study of aspirin and esomeprazole chemoprevention in Barrett's metaplasia.

Trial Documents

In order to access restricted trial documents, click on Log In at the bottom left corner of this page

Study Objectives

To assess whether intervention with aspirin and/or high dose PPI therapy results in decreased mortality or conversion rate from Barrett’s metaplasia to adenocarcinoma or high grade dysplasia.